Dr. David Walling @dpwalling

Clinical Researcher, Ph.D. Psychologist, USC Trojan, Car Enthusiast, Wine Lover and Scuba Diver Huntington Beach, CA Joined January 2012

Tweets

512
Followers

283
Following

383
Likes

100K

Dr. David Walling @dpwalling

2 weeks ago

@AmericanAir have to say - the crew on AA 3166 tonight was great and Sam the flight attendant in FC is a superstar!

1 0 0 39 0

View Details

Dr. David Walling @dpwalling

5 months ago

@Budget this is no way to treat customers! Either have the staff to serve people or don’t do business - everyone is frustrated!

0 0 0 7 0

View Details

Alzheimer's Association @alzassociation

2 years ago

Repost to tell @SteveScalise that the Alzheimer’s and dementia community need him to support a House vote on the #NAPAAct, #AlzInvestmentAct and #BOLDAlzheimersAct. Passing these bipartisan bills will build on our decade-long progress in the fight to #ENDALZ.

6 31 73 134K 2

View Details

Dr. David Walling @dpwalling

2 years ago

@ca_resistance Happily did so yesterday!

2 0 0 10 0

View Details

Eric Feigl-Ding @DrEricDing

2 years ago

💔HEARTBREAKING—These twins need a $4.2 million one-time drug to save their lives (Spinal muscular atrophy). Their mother’s health insurance (and her employer) @Mosaic_LifeCare conveniently told the family the drug was cut from their coverage precisely one day after they were born. Total coincidence, my ass. It’s also a race against the clock to get the treatment Zolgensma for the twins before it’s too late. If Zolgensma is given soon after birth, children may develop no significant disabilities. Children who receive the drug when they are a little older may avoid a feeding or breathing tube, and capable of some movement, rather than a life spent immobile, or death (<2 years usually), if not treated. Zolgensma is sold by @Novartis. The drug sells for $1 million in Brazil, but $2.1 million in the U.S. Also in Brazil, if the child dies of SMA disease within 4 years, part of the $1 million payment is waived. But not in America. Many patients have had to sue health insurance to get the treatment covered—often at the expense of further disability of the untreated child. All this is further enrage, when in fact, federally funded NIH research contributed to the development of Zolgensma. ➡️READ: Taxpayer dollars helped create the drug. Now the public is being shafted. wbtv.com/2024/04/30/new… There is a GoFundme but this shouldn’t be the long term solution for other families. @Mosaic_LifeCare & @Novartis both need to be help accountable. gofundme.com/f/eli-easton-r… durbin.senate.gov/newsroom/press…

242 2K 6K 784K 283

View Details

JAMA Psychiatry @JAMAPsych

2 years ago

Xanomeline-trospium is efficacious & well tolerated in people with schizophrenia experiencing acute psychosis, finds EMERGENT-3 trial, and supports potential of xanomeline-trospium to be first in a putative new class of antipsychotic medications. ja.ma/4dkxa7q